Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuele, S.
Right arrow Articles by Altenmüller, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuele, S.
Right arrow Articles by Altenmüller, E.
Related Collections
Right arrow Dystonia
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrowRelated Articles
NEUROLOGY 2005;64:341-343
© 2005 American Academy of Neurology
Brief Communications

Botulinum toxin injections in the treatment of musician’s dystonia

Stephan Schuele, MD, MPH, Hans-Christian Jabusch, MD, Richard J. Lederman, MD, PhD and Eckart Altenmüller, MD

From the Department of Neurology and Medical Center for Performing Artists (Drs. Schuele and Lederman), The Cleveland Clinic Foundation, OH; and University of Music and Drama (Drs. Jabusch and Altenmüller), Institute of Music Physiology and Musicians’ Medicine, Hannover, Germany.

Address correspondence and reprint requests to Dr. Stephan Schuele, Department of Neurology and Medical Center for Performing Artists/Mailbox S 432, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: schules{at}ccf.org

The authors present the results of 84 musicians with focal task-specific dystonia treated with EMG-guided botulinum toxin injections. Treatment outcome was assessed by subjective estimation of playing before and after treatment and self-rating of treatment response. Fifty-eight (69%) of the musicians experienced improvement from the injections and 30 of 84 musicians (36%) reported long-term benefit in their performance ability.

See also page 186

Presented in part at the 56th American Academy of Neurology annual meeting, San Francisco, CA, 2004.

Received May 17, 2004. Accepted in final form September 15, 2004.


Related Articles

January 25 Highlights
Neurology 2005 64: 180-181. [Full Text] [PDF]

Musician's dystonia
Seth L. Pullman and Anna H. Hristova
Neurology 2005 64: 186-187. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 BMJHome page
S. Bache and F. Edenborough
A symphony of maladies
BMJ, December 12, 2008; 337(dec12_1): a2646 - a2646.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.